Ron Fouchier - Biography#


Ron Fouchier (1966) received a PhD in Medicine from the University of Amsterdam in 1995 for studies on HIV and continued to study HIV as a post-doctoral fellow at the Howard Hughes Medical Institute, University of Pennsylvania School of Medicine in Philadelphia, from 1995-1998. He subsequently started a new group to study the molecular biology of respiratory viruses, in particular influenza A virus, at the Viroscience Department of Erasmus MC Rotterdam. As a fellow of the Royal Dutch Academy of Sciences, he studied influenza virus zoonoses and pathogenicity. Achievements of his team include the identification and characterization of several "new" viruses; the human metapneumovirus (hMPV), human coronavirus NL63, the SARS coronavirus (SARS-CoV), the MERS coronavirus (MERS-CoV), and a new influenza A virus subtype (H16). Currently, his research is focused on the evolution and molecular biology of respiratory viruses in humans and animals, with special emphasis on antigenic drift and influenza virus zoonoses, transmission, and pandemics. His recent basic research on influenza virus transmission via the air and on antigenic drift of influenza viruses is new textbook material.

Fouchier is alumni member of the "Young Academy" of the Royal Dutch Academy of Sciences, elected member of the Royal Dutch Academy of Sciences, elected member of the Royal Holland Society of Sciences and Humanities, recipient of the 2006 Heine-Medin award of the European Society for Clinical Virology and the 2013 Huibregtsen prize for top innovative science with societal impact. He co-authored more than 400 publications that have been cited more than 33,000 times (H index 86). Fouchier acts as editor for several infectious disease journals (currently Section Editor for Plos Pathogens), and member of advisory committees for Dutch government and (international) scientific organisations and conferences. He is Scientific Director of the Graduate School Molecular Medicine at Erasmus MC (~500 PhD students). His group is part of an NIH/NIAID Center of Excellence for Influenza Research, and participates in several WHO working groups. His research is further funded by several EU programs and Dutch and US government.

Imprint Privacy policy « This page (revision-3) was last updated on Wednesday, 3. October 2018, 11:23 by System
  • operated by